nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Localised oedema—Lamivudine—hepatitis B	0.0313	0.0319	CcSEcCtD
Gadopentetate dimeglumine—Serum creatinine increased—Entecavir—hepatitis B	0.0277	0.0283	CcSEcCtD
Gadopentetate dimeglumine—Serum creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0271	0.0276	CcSEcCtD
Gadopentetate dimeglumine—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0208	0.0212	CcSEcCtD
Gadopentetate dimeglumine—Laryngeal pain—Telbivudine—hepatitis B	0.0206	0.021	CcSEcCtD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—hepatitis B	0.0194	1	CrCbGaD
Gadopentetate dimeglumine—Rhinorrhoea—Telbivudine—hepatitis B	0.0173	0.0176	CcSEcCtD
Gadopentetate dimeglumine—Chest discomfort—Telbivudine—hepatitis B	0.0158	0.0161	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactoid reaction—Entecavir—hepatitis B	0.0128	0.013	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.0127	0.0129	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Entecavir—hepatitis B	0.0116	0.0118	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0113	0.0115	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Entecavir—hepatitis B	0.0113	0.0115	CcSEcCtD
Gadopentetate dimeglumine—Throat sore—Lamivudine—hepatitis B	0.011	0.0112	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0109	0.0111	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Telbivudine—hepatitis B	0.0107	0.0109	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Telbivudine—hepatitis B	0.0102	0.0104	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Telbivudine—hepatitis B	0.01	0.0102	CcSEcCtD
Gadopentetate dimeglumine—Rhinorrhoea—Lamivudine—hepatitis B	0.00975	0.00994	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Entecavir—hepatitis B	0.00938	0.00957	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Telbivudine—hepatitis B	0.00929	0.00947	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00915	0.00933	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Telbivudine—hepatitis B	0.0091	0.00928	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Entecavir—hepatitis B	0.00902	0.0092	CcSEcCtD
Gadopentetate dimeglumine—Vasodilation procedure—Lamivudine—hepatitis B	0.00899	0.00917	CcSEcCtD
Gadopentetate dimeglumine—Vasodilation—Lamivudine—hepatitis B	0.00899	0.00917	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0088	0.00898	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal pain—Lamivudine—hepatitis B	0.00868	0.00886	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Entecavir—hepatitis B	0.00844	0.00861	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Telbivudine—hepatitis B	0.00843	0.00859	CcSEcCtD
Gadopentetate dimeglumine—Hearing impaired—Lamivudine—hepatitis B	0.0083	0.00846	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00825	0.00842	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00821	0.00838	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00819	0.00835	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Entecavir—hepatitis B	0.00774	0.00789	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Telbivudine—hepatitis B	0.00771	0.00786	CcSEcCtD
Gadopentetate dimeglumine—Wheezing—Lamivudine—hepatitis B	0.00767	0.00782	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Entecavir—hepatitis B	0.0075	0.00765	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00741	0.00756	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00704	0.00718	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Telbivudine—hepatitis B	0.00691	0.00705	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Lamivudine—hepatitis B	0.00665	0.00679	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Lamivudine—hepatitis B	0.00641	0.00653	CcSEcCtD
Gadopentetate dimeglumine—Cough—Adefovir Dipivoxil—hepatitis B	0.00635	0.00647	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Telbivudine—hepatitis B	0.00634	0.00647	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0063	0.00643	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00619	0.00632	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00615	0.00627	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Entecavir—hepatitis B	0.00609	0.00621	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Lamivudine—hepatitis B	0.00602	0.00614	CcSEcCtD
Gadopentetate dimeglumine—Thirst—Lamivudine—hepatitis B	0.00602	0.00614	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Telbivudine—hepatitis B	0.006	0.00612	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Entecavir—hepatitis B	0.00597	0.00609	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Telbivudine—hepatitis B	0.00593	0.00604	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Entecavir—hepatitis B	0.00591	0.00603	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00582	0.00594	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00577	0.00588	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00566	0.00577	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Lamivudine—hepatitis B	0.00564	0.00575	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Telbivudine—hepatitis B	0.00552	0.00563	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Entecavir—hepatitis B	0.00541	0.00552	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00541	0.00552	CcSEcCtD
Gadopentetate dimeglumine—Cough—Telbivudine—hepatitis B	0.00535	0.00545	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Entecavir—hepatitis B	0.00525	0.00536	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Entecavir—hepatitis B	0.00525	0.00535	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Lamivudine—hepatitis B	0.00524	0.00534	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Telbivudine—hepatitis B	0.00522	0.00532	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Telbivudine—hepatitis B	0.00522	0.00532	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00518	0.00528	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00516	0.00526	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00513	0.00523	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Lamivudine—hepatitis B	0.00513	0.00523	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Entecavir—hepatitis B	0.00498	0.00507	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Telbivudine—hepatitis B	0.0049	0.005	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Telbivudine—hepatitis B	0.00486	0.00495	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00486	0.00495	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Entecavir—hepatitis B	0.00481	0.00491	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Entecavir—hepatitis B	0.00481	0.00491	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Lamivudine—hepatitis B	0.00475	0.00484	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00469	0.00479	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00469	0.00479	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Lamivudine—hepatitis B	0.00458	0.00467	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00455	0.00464	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Telbivudine—hepatitis B	0.00449	0.00458	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Entecavir—hepatitis B	0.00437	0.00445	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Lamivudine—hepatitis B	0.00434	0.00443	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00432	0.0044	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Telbivudine—hepatitis B	0.00431	0.0044	CcSEcCtD
Gadopentetate dimeglumine—Pain—Telbivudine—hepatitis B	0.00428	0.00436	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00426	0.00434	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Lamivudine—hepatitis B	0.00424	0.00432	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0042	0.00428	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00418	0.00426	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Entecavir—hepatitis B	0.00416	0.00425	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Telbivudine—hepatitis B	0.00412	0.0042	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00409	0.00417	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00406	0.00414	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Entecavir—hepatitis B	0.00402	0.0041	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Lamivudine—hepatitis B	0.00398	0.00405	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Telbivudine—hepatitis B	0.00395	0.00403	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Telbivudine—hepatitis B	0.00395	0.00403	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Lamivudine—hepatitis B	0.0039	0.00397	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Entecavir—hepatitis B	0.00387	0.00395	CcSEcCtD
Gadopentetate dimeglumine—Rash—Entecavir—hepatitis B	0.00384	0.00391	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Entecavir—hepatitis B	0.00383	0.00391	CcSEcCtD
Gadopentetate dimeglumine—Headache—Entecavir—hepatitis B	0.00381	0.00389	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00378	0.00385	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Lamivudine—hepatitis B	0.00375	0.00382	CcSEcCtD
Gadopentetate dimeglumine—Rash—Adefovir Dipivoxil—hepatitis B	0.00374	0.00382	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00374	0.00381	CcSEcCtD
Gadopentetate dimeglumine—Headache—Adefovir Dipivoxil—hepatitis B	0.00372	0.00379	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Entecavir—hepatitis B	0.00361	0.00369	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Telbivudine—hepatitis B	0.00359	0.00366	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Lamivudine—hepatitis B	0.00358	0.00365	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Lamivudine—hepatitis B	0.00357	0.00364	CcSEcCtD
Gadopentetate dimeglumine—Chills—Lamivudine—hepatitis B	0.00356	0.00363	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Telbivudine—hepatitis B	0.00354	0.00361	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00353	0.0036	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Lamivudine—hepatitis B	0.00345	0.00352	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Telbivudine—hepatitis B	0.00342	0.00349	CcSEcCtD
Gadopentetate dimeglumine—Tension—Lamivudine—hepatitis B	0.00339	0.00345	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Lamivudine—hepatitis B	0.00338	0.00345	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Lamivudine—hepatitis B	0.00334	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Telbivudine—hepatitis B	0.00331	0.00337	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Lamivudine—hepatitis B	0.00323	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Telbivudine—hepatitis B	0.00318	0.00324	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Lamivudine—hepatitis B	0.00315	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Rash—Telbivudine—hepatitis B	0.00315	0.00321	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Telbivudine—hepatitis B	0.00315	0.00321	CcSEcCtD
Gadopentetate dimeglumine—Headache—Telbivudine—hepatitis B	0.00313	0.00319	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Lamivudine—hepatitis B	0.00311	0.00317	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Lamivudine—hepatitis B	0.0031	0.00316	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Lamivudine—hepatitis B	0.00303	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Cough—Lamivudine—hepatitis B	0.00301	0.00307	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Lamivudine—hepatitis B	0.00299	0.00305	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Telbivudine—hepatitis B	0.00297	0.00303	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Lamivudine—hepatitis B	0.00294	0.003	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Lamivudine—hepatitis B	0.00294	0.003	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Lamivudine—hepatitis B	0.00293	0.00299	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00292	0.00298	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Lamivudine—hepatitis B	0.00287	0.00293	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Lamivudine—hepatitis B	0.00284	0.0029	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Lamivudine—hepatitis B	0.00282	0.00287	CcSEcCtD
Gadopentetate dimeglumine—Shock—Lamivudine—hepatitis B	0.00277	0.00283	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Lamivudine—hepatitis B	0.00276	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Lamivudine—hepatitis B	0.00274	0.00279	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Lamivudine—hepatitis B	0.00272	0.00278	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Lamivudine—hepatitis B	0.00269	0.00274	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Lamivudine—hepatitis B	0.00263	0.00268	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00257	0.00262	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Lamivudine—hepatitis B	0.00253	0.00258	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Lamivudine—hepatitis B	0.00251	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Lamivudine—hepatitis B	0.0025	0.00255	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Lamivudine—hepatitis B	0.00245	0.0025	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00243	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Lamivudine—hepatitis B	0.00243	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Pain—Lamivudine—hepatitis B	0.00241	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Lamivudine—hepatitis B	0.00241	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Lamivudine—hepatitis B	0.00232	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Lamivudine—hepatitis B	0.0023	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Lamivudine—hepatitis B	0.00224	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Lamivudine—hepatitis B	0.00223	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Lamivudine—hepatitis B	0.00223	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Lamivudine—hepatitis B	0.00208	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Lamivudine—hepatitis B	0.00202	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Lamivudine—hepatitis B	0.00199	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Lamivudine—hepatitis B	0.00193	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Lamivudine—hepatitis B	0.00186	0.0019	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Lamivudine—hepatitis B	0.00179	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Rash—Lamivudine—hepatitis B	0.00178	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Lamivudine—hepatitis B	0.00177	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Headache—Lamivudine—hepatitis B	0.00177	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Lamivudine—hepatitis B	0.00167	0.00171	CcSEcCtD
